- Home
- TCMD vs ORIC Comparison
TCMD vs ORIC Comparison
Compare TCMD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- ORIC
- Stock Information
- Founded
- TCMD 1995
- ORIC 2014
- Country
- TCMD United States
- ORIC United States
- Employees
- TCMD N/A
- ORIC N/A
- Industry
- TCMD Medical/Dental Instruments
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- ORIC Health Care
- Exchange
- TCMD Nasdaq
- ORIC Nasdaq
- Market Cap
- TCMD 314.0M
- ORIC 362.9M
- IPO Year
- TCMD 2016
- ORIC 2020
- Fundamental
- Price
- TCMD $9.97
- ORIC $9.35
- Analyst Decision
- TCMD Hold
- ORIC Strong Buy
- Analyst Count
- TCMD 3
- ORIC 8
- Target Price
- TCMD $16.00
- ORIC $18.83
- AVG Volume (30 Days)
- TCMD 289.6K
- ORIC 2.1M
- Earning Date
- TCMD 08-04-2025
- ORIC 08-11-2025
- Dividend Yield
- TCMD N/A
- ORIC N/A
- EPS Growth
- TCMD N/A
- ORIC N/A
- EPS
- TCMD 0.66
- ORIC N/A
- Revenue
- TCMD $293,164,000.00
- ORIC N/A
- Revenue This Year
- TCMD $7.96
- ORIC N/A
- Revenue Next Year
- TCMD $8.53
- ORIC N/A
- P/E Ratio
- TCMD $15.10
- ORIC N/A
- Revenue Growth
- TCMD 5.96
- ORIC N/A
- 52 Week Low
- TCMD $8.61
- ORIC $3.90
- 52 Week High
- TCMD $21.10
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- TCMD 41.97
- ORIC 62.84
- Support Level
- TCMD $9.80
- ORIC $8.85
- Resistance Level
- TCMD $10.67
- ORIC $9.54
- Average True Range (ATR)
- TCMD 0.34
- ORIC 0.74
- MACD
- TCMD 0.09
- ORIC -0.07
- Stochastic Oscillator
- TCMD 19.54
- ORIC 50.98
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.